High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial

Anna Laurell; Arne Kolstad; Mats Jerkeman; Riikka Raty; Christian H. Geisler

doi:10.3109/10428194.2013.825906

High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial

Anna Laurell, Arne Kolstad, Mats Jerkeman, Riikka Raty, Christian H. Geisler

Breastcancer-genetics

Research output: Contribution to journal › Letter

289 Downloads (Pure)

Original language	English
Pages (from-to)	1206-1208
Journal	Leukemia & Lymphoma
Volume	55
Issue number	5
DOIs	https://doi.org/10.3109/10428194.2013.825906
Publication status	Published - 2014

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428194.2013.825906

Informa_Healthcare__Laurell_et_al

Cite this

@article{d6e5ab2aff084132a718c67b831a9d52,

title = "High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial",

author = "Anna Laurell and Arne Kolstad and Mats Jerkeman and Riikka Raty and Geisler, {Christian H.}",

year = "2014",

doi = "10.3109/10428194.2013.825906",

language = "English",

volume = "55",

pages = "1206--1208",

journal = "Leukemia & Lymphoma",

issn = "1042-8194",

publisher = "Taylor & Francis",

number = "5",

}

TY - JOUR

T1 - High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial

AU - Laurell, Anna

AU - Kolstad, Arne

AU - Jerkeman, Mats

AU - Raty, Riikka

AU - Geisler, Christian H.

PY - 2014

Y1 - 2014

U2 - 10.3109/10428194.2013.825906

DO - 10.3109/10428194.2013.825906

M3 - Letter

C2 - 23876100

SN - 1042-8194

VL - 55

SP - 1206

EP - 1208

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

IS - 5

ER -